SAN FRANCISCO, LOS ANGELES & SAN DIEGO--(BUSINESS WIRE)--Biocom California, the association representing the California life science industry, today announced the winners of its seventh annual Life Science Catalyst Awards. The awards celebrate the accomplished and up-and-coming academics, entrepreneurs, investors, corporate leaders and business advisers who are making their mark on the California life science industry before reaching their 40th birthday.
“The Catalyst Awards highlight the impressive spectrum of talent and tenacity present in the next generation of leaders in the life science industry,” said Joe Panetta, president and CEO of Biocom California. “This year’s winners are paving the way for future innovation and exemplify the ingenuity and passion that will propel the industry forward. I am proud to highlight the 2022 Catalyst Award winners and applaud their commitment to positively impacting California’s ecosystem.”
Biocom California selected the 10 winners from an impressive pool of nominees from all facets of the life science industry, including pharma, diagnostics, venture funding, industrial biotech and digital health. The nominees were vetted statewide by a panel of industry leaders, subject matter experts, and past winners that considered factors including impact to their company, impact to their community and industry, accomplishments, leadership and innovation.
In alphabetical order, the Life Science Catalyst Award winners are:
- Jun Axup, PhD, director of partnerships at E11 Bio
- Monica Rivera Beam, PhD, senior vice president of science & technology at Alexandria Real Estate Equities, Inc., and Alexandria Venture Investments
- Janice Chen, PhD, co-founder and chief technology officer of Mammoth Biosciences, Inc.
- Elizabeth Redman Cleveland, chief strategist of sustainable growth at City of Berkeley
- Michael Farrington, chief people and culture officer at NuVasive
- Peyton Greenside, PhD, co-founder and chief scientific officer at BigHat Biosciences
- Genevieve LeMarchal, managing partner at Suncoast Ventures and head of healthcare at Expert Dojo
- Devan Shah, chief executive officer and founder of RNAV8 Bio
- Samir Siddhanti, executive director of business development at Neurocrine Biosciences
- Hanadie Yousef, PhD, chief executive officer and co-founder of Juvena Therapeutics, Inc.
The award winners will be highlighted in the Biocom California LifeLines digital platform and newsletter and celebrated at the annual “Celebration of Life” Gala on November 10, 2022.
About Biocom California
Biocom California is the leader and advocate for California’s life science sector. We work on behalf of more than 1,700 members to drive public policy, build an enviable network of industry leaders, create access to capital, introduce cutting-edge STEM education programs and create robust value-driven purchasing programs.
Founded in 1995 in San Diego, Biocom California provides the strongest public voice to research institutions and companies that fuel the local and state-wide economy. Our goal is simple: to help our members produce novel solutions that improve the human condition. In addition to our San Diego headquarters, Biocom California operates core offices in Los Angeles and the San Francisco Bay Area, with satellite offices in Sacramento, Washington, D.C. and Tokyo. Our broad membership benefits apply to biotechnology, pharmaceutical, medical device, genomics and diagnostics companies of all sizes, as well as to research universities and institutes, clinical research organizations, investors and service providers.
For more information on Biocom California, please visit our website at www.biocom.org. Connect with us on LinkedIn, Facebook, and Twitter (@BIOCOMCA).
